Cardiokine, Inc., a specialty pharmaceutical company, appointed Amber Salzman, Ph.D., President and Chief Executive Officer and a member of the Board of Directors. Amber had been Senior Vice President of Operations for Medicines Development at GlaxoSmithKline. Read more in the Business Wire press release.
Recent Comments